Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors
Autor: | Priller, J., Briley, E. M., Mansouri, J., Devane, W. A., Ken Mackie, Felder, C. C. |
---|---|
Zdroj: | Scopus-Elsevier The Lens ResearcherID |
Databáze: | OpenAIRE |
Externí odkaz: |